The CANARY Study is nation-wide study, led by Lynda Balneaves (UBC School of Nursing) is examining the impact of the regulatory changes on patient access to cannabis for medical purposes, as well as the impact on health outcomes and health care utilization.
The study will focus on patients living with acute or chronic health conditions, such as cancer, HIV/AIDS, arthritis, and chronic pain who are accessing cannabis through the MMAR, those accessing it through the MMPR, and those not accessing it through either government program. We will also be following patients who do not currently use cannabis for medical purposes.
We will be following patients through the changes for the next year. There will be 3 online surveys to fill out during that time, as well as interviews for a small subset of participants.
The first survey must be completed by May 1st.
Please share widely with your clients and networks.